Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sutro Biopharma, Inc. (STRO) had Weighted-Average Shares Outstanding (Diluted) of 83.11M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$17.40M |
|
$-75.97M |
|
-- |
|
$17.40M |
|
$85.91M |
|
$-68.51M |
|
$-7.45M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-68.51M |
|
$-67.73M |
|
83.11M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
83.11M |
$-0.91 |
|
$-0.91 |
|
| Balance Sheet Financials | |
$287.41M |
|
$16.80M |
|
$34.02M |
|
$321.43M |
|
$133.05M |
|
-- |
|
$214.19M |
|
$347.24M |
|
$-25.81M |
|
$-25.81M |
|
$-25.81M |
|
84.35M |
|
| Cash Flow Statement Financials | |
$-67.88M |
|
$-16.26M |
|
$0.07M |
|
$191.16M |
|
$107.09M |
|
$-84.08M |
|
$5.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-393.78% |
|
-393.78% |
|
-- |
|
-436.62% |
|
-436.62% |
|
$-69.06M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
1.28 |
|
70.15 |
|
294.32% |
|
294.32% |
|
-23.63% |
|
294.32% |
|
$-0.31 |
|
$-0.83 |
|
$-0.82 |
|